Screening for impaired liver function as a risk factor for drug safety at hospital admission of surgical patients.

Abstract:

:Background Hepatic insufficiency can affect patient safety and should therefore be considered during drug therapy. Hospital admission offers an ideal point to screen for patients at risk and to adjust drug therapy accordingly. Objective To assess the number of patients admitted to hospital with clinically elevated liver parameters. To identify high-risk patients in need of potential drug therapy adjustment to liver function by calculation of liver scores. Finally, to investigate whether pre-hospital medication needed adjustment to liver function. Setting Patients admitted to surgical wards of a tertiary teaching hospital. Method Surgical patients were included in a 3-month retrospective study. A pharmacist-led screening process, including recording of elevated liver parameters and calculation of liver scores (Child-Pugh-score, Model of End-stage Liver Disase [MELD], MELDNa), was used to assess frequency of hepatic insufficiency and patients potentially needing medication adjustment. Additionally, pre-hospital medication was checked for contraindications and correct dosage with regard to liver function. Main outcome measure Percentage of surgical patients with clinically elevated liver parameters at admission, percentage of patients with hepatic insufficiency potentially needing drug therapy adjustment, and percentage of pre-hospital drug intakes not adjusted to liver function. Results Of 1200 patients, 130 (11%) had at least one clinically relevant elevated liver parameter at hospital admission. Of these, need for drug adjustment to liver function was found for 16-36%, depending on the liver score used (equivalent to 2-4% of all patients), with the highest number of patients detected by the MELD- and MELDNa-score. Pre-hospital medication concerned 719 drug intakes and was contraindicated in 2%, dosage not adjusted in 3%, and evaluation not possible in 44% of all drug intakes due to lack of information on the drug. Conclusion A significant proportion of patients admitted for surgery have clinically elevated liver parameters and potentially need medication adjustment. A pharmacist-led screening already at hospital admission can support the identification of patients with clinically relevant elevated liver parameters and patients at risk by calculating liver scores under routine conditions. Evaluation of drug adjustment to liver function is challenging, since no data are available in routine resources for a considerable number of drugs.

journal_name

Int J Clin Pharm

authors

Strobach D,Poppele A,Mannell H,Andraschko M,Schiek S,Bertsche T

doi

10.1007/s11096-019-00948-7

subject

Has Abstract

pub_date

2020-02-01 00:00:00

pages

124-131

issue

1

eissn

2210-7703

issn

2210-7711

pii

10.1007/s11096-019-00948-7

journal_volume

42

pub_type

杂志文章
  • Drug related problems identified by community pharmacists on hospital discharge prescriptions in New Zealand.

    abstract:BACKGROUND:There can be a lack of transfer of information between hospitals and community pharmacies following patient discharge, which puts patients at a high risk of suffering drug related problems (DRPs). Community pharmacy plays a vital role in identifying and solving these discharge DRPs and taking action before t...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-014-9935-8

    authors: Braund R,Coulter CV,Bodington AJ,Giles LM,Greig AM,Heaslip LJ,Marshall BJ

    更新日期:2014-06-01 00:00:00

  • Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.

    abstract:BACKGROUND:Both clinical pharmacists and computerized physician order entry systems with clinical decision support (CPOE/CDSS) can reduce drug-related problems (DRPs). However, the contribution of a clinical pharmacist in addition to CPOE/CDSS has not been established in a prospective study. OBJECTIVE:To determine whi...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-013-9798-4

    authors: Zaal RJ,Jansen MM,Duisenberg-van Essenberg M,Tijssen CC,Roukema JA,van den Bemt PM

    更新日期:2013-10-01 00:00:00

  • Pharmacy-supported interventions at transitions of care: an umbrella review.

    abstract::Background Medication discrepancies arising at care transitions are prevalent and are linked with adverse drug events and increased healthcare utilization. Evidence is lacking about which pharmacy-supported interventions at care transitions are most effective for both the patient and the healthcare system. Aim of the ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章,评审

    doi:10.1007/s11096-019-00833-3

    authors: Cebron Lipovec N,Zerovnik S,Kos M

    更新日期:2019-08-01 00:00:00

  • Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise.

    abstract::Background Oral anticoagulation therapy has proven beneficial impact on the prevention of thromboembolic events. However, the use of antocoagulatns also increases the risk of bleeds. To maximize the benefits and minimize the risks of the treatment, guidance on appropriate use of oral anticoagulants is essential. An in...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00844-0

    authors: Damen NL,Van den Bemt BJF,Hersberger KE,Papastergiou J,Alves da Costa F,Rydant S,Wartenberg NS,Lobban T,Arnet I,Antoniou S,International Pharmacists for Anticoagulation Care Taskforce (iPACT).

    更新日期:2019-08-01 00:00:00

  • The acceptability of a direct oral anticoagulant monitoring regimen among patients with atrial fibrillation: a pilot study.

    abstract::Background The direct oral anticoagulants (DOACs) offer several advantages over warfarin in the management atrial fibrillation, including the provision of fixed dosing without a requirement for regular monitoring. Recently however the subject of DOAC monitoring has been probed after several post-hoc analyses demonstra...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00830-6

    authors: Mourad AP,Aslani P,D'Souza M,Brieger D

    更新日期:2019-06-01 00:00:00

  • Implementation of an IT-guided checklist to improve the quality of medication history records at hospital admission.

    abstract::Background Medication discrepancies often occur at transition of care such as hospital admission and discharge. Obtaining a complete and accurate medication history on admission is essential as further treatment is based on it. Objective The goal of this study was to reduce the proportion of patients with at least one...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-017-0545-0

    authors: Huber T,Brinkmann F,Lim S,Schröder C,Stekhoven DJ,Marti WR,Egger RR

    更新日期:2017-12-01 00:00:00

  • Comparing remifentanil and sufentanil in stress reduction during neurosurgery: a randomised controlled trial.

    abstract::Background In most scenarios, anaesthesiologists titrate opioids to control nociceptive surgical stress based on intraoperative haemodynamic changes. Remifentanil was reported to cause more profound cardiovascular depression than sufentanil. A concern is that this direct cardiovascular depression might counteract the ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01094-1

    authors: Liu YH,Hu XB,Yang XM,Wang YW,Deng M

    更新日期:2020-10-01 00:00:00

  • The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients.

    abstract::Background The treatment of heart failure patients is very complex and includes lifestyle modification as well as different pharmacological therapies. Polypharmacy is very common in such patients and they are at increased risk of potential drug-drug interactions and associated effects such as poor adherence, complianc...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00918-z

    authors: Georgiev KD,Hvarchanova N,Georgieva M,Kanazirev B

    更新日期:2019-12-01 00:00:00

  • Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.

    abstract:BACKGROUND:Drug safety has major implications for patients' lives. However, this concept is still considered new to some healthcare professionals. OBJECTIVE:This study aims to investigate the knowledge and awareness of Saudi healthcare professionals to pharmacovigilance (PV). Setting Governmental and private hospitals...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0165-5

    authors: Alshammari TM,Alamri KK,Ghawa YA,Alohali NF,Abualkol SA,Aljadhey HS

    更新日期:2015-12-01 00:00:00

  • Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine.

    abstract:OBJECTIVES:Diabetes mellitus is a chronic progressive disease characterized by numerous health complications. Medication adherence is an important determinant of therapeutic outcome. Few studies on medication adherence have been published from the Arab countries. Therefore, the objective of this pilot study was to asse...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-011-9561-7

    authors: Jamous RM,Sweileh WM,Abu-Taha AS,Sawalha AF,Zyoud SH,Morisky DE

    更新日期:2011-12-01 00:00:00

  • A possible effect of montelukast on neurological aging examined by the use of register data.

    abstract::Background The leukotriene receptor antagonist montelukast has been shown to rejuvenate aged brains in rats; however, data on humans are still scarce. Objective To investigate if montelukast may alleviate degenerative neurological changes using a register data. Setting Norwegian registry data analyses. Method The pres...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01160-8

    authors: Grinde B,Schirmer H,Eggen AE,Aigner L,Engdahl B

    更新日期:2020-10-09 00:00:00

  • Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis.

    abstract::Background Rheumatoid arthritis is a chronic, autoimmune disease in which treatment has evolved with a variety of therapeutic classes. Biological disease-modifying antirheumatic drugs have improved therapy; however, the continued long-term use of these drugs with sustained safety and efficacy remains a challenge. Obje...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01171-5

    authors: Gomides APM,de Albuquerque CP,Santos ABV,Bértolo MB,Júnior PL,Giorgi RDN,Radominski SC,Resende Guimarães MFB,Bonfiglioli KR,de Fátima Lobato da Cunha Sauma M,Pereira IA,Brenol CV,da Mota LMH,Pinheiro GDRC

    更新日期:2020-10-21 00:00:00

  • Unintentional and intentional non-adherence to immunosuppressive medications in renal transplant recipients.

    abstract::Background Non-adherence to immunosuppressive medications following renal transplantation is a risk factor for rejection and graft loss. Despite the dire consequences, adherence lapses, both unintentional and intentional, are common and poorly understood. Objective The present study sets to compare the rates and deter...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0652-6

    authors: Griva K,Neo HLM,Vathsala A

    更新日期:2018-10-01 00:00:00

  • An analysis of unused and expired medications in Mexican households.

    abstract:BACKGROUND:Unsafe storage of unused medications at home leads to an increased risk of toxicity, accidental childhood poisoning or risk for suicide, whereas an improper disposal of unwanted/expired medications from household raises concern about environmental pollution. OBJECTIVE:The aim of the study was to characteriz...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-014-0048-1

    authors: Gracia-Vásquez SL,Ramírez-Lara E,Camacho-Mora IA,Cantú-Cárdenas LG,Gracia-Vásquez YA,Esquivel-Ferriño PC,Ramírez-Cabrera MA,Gonzalez-Barranco P

    更新日期:2015-02-01 00:00:00

  • Doctors' perceptions, expectations and experience regarding the role of pharmacist in hospital settings of Pakistan.

    abstract::Background The inclusion of pharmacist in health care system is essential to ensure optimal patient care. However, with the passage of time, pharmacist's role has transcended from dispensing, compounding and counting of pills, to more sophisticated clinical duties. Objective To evaluate doctors' experience, perception...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-00991-9

    authors: Khan N,McGarry K,Naqvi AA,Holden K

    更新日期:2020-04-01 00:00:00

  • Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.

    abstract::Background Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used pharmaceutical agents worldwide. NSAIDs are considered nephrotoxic and should therefore be used with caution or be avoided completely in high risk patients, such as chronic kidney disease (CKD) patients. Objective This study aim...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-016-0298-1

    authors: Meuwesen WP,du Plessis JM,Burger JR,Lubbe MS,Cockeran M

    更新日期:2016-08-01 00:00:00

  • Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.

    abstract::Background The challenges of under-reporting of adverse drug reactions have been identified as a major setback for the pharmacovigilance system worldwide. Direct reporting by health care consumers has been adopted in some developed and developing countries with a positive impact in improving pharmacovigilance activiti...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章,评审

    doi:10.1007/s11096-020-01141-x

    authors: Adedeji-Adenola H,Nlooto M

    更新日期:2020-09-09 00:00:00

  • Recommendations to support deprescribing medications late in life.

    abstract::It is widely acknowledged that patients-particularly those late in life-are frequently exposed to the harms of medication. To minimize these harms, several frameworks have been developed by which prescribing can be optimized. In the context of diminishing life expectancy, these frameworks can be used to reduce medicat...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0148-6

    authors: Todd A,Holmes HM

    更新日期:2015-10-01 00:00:00

  • Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar.

    abstract:BACKGROUND:Older patients receiving home health care are particularly at risk of receiving potentially inappropriate medications compared to community-dwelling population. Data on appropriateness of prescribing in these patients is limited. OBJECTIVE:To investigate the prevalence, patterns and determinants of potentia...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0125-0

    authors: Alhmoud E,Khalifa S,Bahi AA

    更新日期:2015-10-01 00:00:00

  • A quantitative comparison of ward-based clinical pharmacy activities in 7 acute UK hospitals.

    abstract::Background Several clinical pharmacy activities are common to UK hospitals. It is not clear whether these are provided at similar levels, and whether they take similar amounts of time to carry out. Objective To quantify and compare clinical pharmacist ward activities between different UK hospitals. Setting Seven acute...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11096-016-0386-2

    authors: Onatade R,Miller G,Sanghera I

    更新日期:2016-12-01 00:00:00

  • Quality of drug information database research for clinical decision support.

    abstract::This commentary identifies studies that have compared commercially available DI databases, and discusses improvements in study methodology that might better guide clinicians in selecting resources for their practice setting. We also provide suggestions for future direction of research in this area with an eye towards ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章,评审

    doi:10.1007/s11096-011-9522-1

    authors: Hoody DW,Beckett CF,Zielenski C,Moore GD

    更新日期:2011-08-01 00:00:00

  • Controversy and consensus on a clinical pharmacist in primary care in the Netherlands.

    abstract:UNLABELLED:Background Controversy about the introduction of a non-dispensing pharmacist in primary care practice hampers implementation. Objective The aim of this study is to systematically map the debate on this new role for pharmacists amongst all stakeholders to uncover and understand the controversy and consensus. ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-016-0360-z

    authors: Hazen AC,Wal AW,Sloeserwij VM,Zwart DL,Gier JJ,Wit NJ,Leendertse AJ,Bouvy ML,Bont AA

    更新日期:2016-10-01 00:00:00

  • Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff.

    abstract::Background Atopic dermatitis affects 10-20% of the children worldwide. Unfortunately not all patients who receive treatment have optimal treatment outcomes. Objective To assess the view of parents and pharmacy staff in order to optimize pharmaceutical care for young atopic dermatitis patients. Setting Community pharma...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00827-1

    authors: Koster ES,Philbert D,Wagelaar KR,Galle S,Bouvy ML

    更新日期:2019-06-01 00:00:00

  • Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability.

    abstract::This article reviews the implications of off-label (OL) and unlicensed (UL) medicine use with respect to the legal duty to inform patients and the liability for failure to provide the patient with adequate information on benefits and risks. Informed consent is a legal prerequisite to any medical treatment and requires...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0646-4

    authors: Aagaard L,Kristensen K

    更新日期:2018-06-01 00:00:00

  • Pharmacists' attitudes towards an evidence-based approach for over-the-counter medication.

    abstract:BACKGROUND:With increasing deregulation of prescription-only medicines and drive for self-care, pharmacists have greater scope to manage more conditions. This brings added responsibility to be competent healthcare professionals who deliver high quality evidence-based patient care. OBJECTIVE:This study sought to establ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-011-9586-y

    authors: Hanna LA,Hughes CM

    更新日期:2012-02-01 00:00:00

  • Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly.

    abstract::Background Population-based studies investigating indications for antidepressant prescribing mostly rely on diagnoses from general practitioners. However, diagnostic codes might be incomplete and drugs may be prescribed 'off-label' for indications not investigated in clinical trials. Objective We aimed to study indica...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-016-0371-9

    authors: Aarts N,Noordam R,Hofman A,Tiemeier H,Stricker BH,Visser LE

    更新日期:2016-10-01 00:00:00

  • Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs.

    abstract::Background Half of Americans experience mental illness during their lifetime. Significant opportunity exists for community pharmacists to deliver services to these patients; however, personal and practice-related barriers may prevent full engagement. Objective To assess the demographics, practice characteristics, serv...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0619-7

    authors: Giannetti V,Caley CF,Kamal KM,Covvey JR,McKee J,Wells BG,Najarian DM,Dunn TJ,Vadagam P

    更新日期:2018-10-01 00:00:00

  • Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements.

    abstract:BACKGROUND:Communication between hospital and community pharmacists when a patient is discharged from hospital can improve the accuracy of medication reconciliation, thus preventing unintentional changes and ensuring continuity of supply. It allows problems to be resolved before a patient requires a further supply of m...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-013-9813-9

    authors: Urban R,Paloumpi E,Rana N,Morgan J

    更新日期:2013-10-01 00:00:00

  • What do hospital staff in the UK think are the causes of penicillin medication errors?

    abstract:BACKGROUND:Medication errors are a potential major threat to patient's health, and allergic reactions occurring in patients with known allergies are an important preventable form of adverse drug event. The use of penicillin antibiotics in patients who are allergic to penicillin, in particular, is a major concern. AIM:...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-012-9708-1

    authors: Wilcock M,Harding G,Moore L,Nicholls I,Powell N,Stratton J

    更新日期:2013-02-01 00:00:00

  • Genetic polymorphisms of high platelet reactivity in Chinese patients with coronary heart disease under clopidogrel therapy.

    abstract:BACKGROUND:The variability in the clinical response to clopidogrel treatment has been attributed to genetic factors, but the specific genes and other risk factors remain unclear. OBJECTIVE:To investigate the incidence of high on-treatment platelet reactivity in coronary heart disease patients following clopidogrel the...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00953-w

    authors: Zou X,Deng XL,Wang YM,Li JH,Liu L,Huang X,Liu L,Cao J,Fan L

    更新日期:2020-02-01 00:00:00